Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Certolizumab pegol and its role in pregnancy-age hidradenitis suppurativa.
Repetto F, Burzi L, Ramondetta A, Rozzo G, Licciardello M, Ribero S, Quaglino P, Dapavo P. Repetto F, et al. Among authors: licciardello m. Int J Dermatol. 2022 May;61(5):e182-e184. doi: 10.1111/ijd.15742. Epub 2021 Jul 16. Int J Dermatol. 2022. PMID: 34270087 No abstract available.
Effectiveness of Secukinumab in the treatment of moderate-severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real-life setting.
Ribero S, Ramondetta A, Fabbrocini G, Bettoli V, Potenza C, Chiricozzi A, Licciardello M, Marzano AV, Bianchi L, Rozzo G, Fania L, Marasca C, Odorici G, Mambrin A, Moltrasio C, Caposiena Caro RD, Skroza N, Quaglino P, Siliquini N, Dapavo P. Ribero S, et al. Among authors: licciardello m. J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e441-e442. doi: 10.1111/jdv.17178. Epub 2021 Mar 9. J Eur Acad Dermatol Venereol. 2021. PMID: 33594790 No abstract available.
Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients?
Ramondetta A, Panzone M, Dapavo P, Ortoncelli M, Giura MT, Licciardello M, Rozzo G, Siliquini N, Fierro MT, Ribero S. Ramondetta A, et al. Among authors: licciardello m. J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e440-e441. doi: 10.1111/jdv.16636. Epub 2020 Jun 8. J Eur Acad Dermatol Venereol. 2020. PMID: 32421876 Free PMC article. No abstract available.
Risankizumab shows faster response in bio naïve than in bio-experienced psoriatic patients.
Mastorino L, Castelli F, Stroppiana E, Verrone A, Ortoncelli M, Susca S, Boskovic S, Passerini SG, Macagno N, Cariti C, Licciardello M, Solaroli C, Pertusi G, Aragone MG, Baggini G, Addese C, Leporati C, Peila R, Giura MT, Rossotto G, Pella P, Mocci L, Merlo G, Tiberio R, Graziola F, Quaglino P, Dapavo P, Ribero S. Mastorino L, et al. Among authors: licciardello m. J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e838-e841. doi: 10.1111/jdv.18314. Epub 2022 Jun 22. J Eur Acad Dermatol Venereol. 2022. PMID: 35686942 No abstract available.
Infection risk in patients with autoimmune cytopenias and immune dysregulation treated with mycophenolate mofetil and sirolimus.
Comella M, Palmisani E, Mariani M, Dell'Orso G, Licciardello M, Giarratana MC, Arcuri L, Pestarino S, Grossi A, Lanciotti M, Brucci G, Guardo D, Russo G, Dufour C, Fioredda F, Castagnola E, Miano M. Comella M, et al. Among authors: licciardello m. Front Immunol. 2024 May 30;15:1415389. doi: 10.3389/fimmu.2024.1415389. eCollection 2024. Front Immunol. 2024. PMID: 38873600 Free PMC article.
53 results